Zymeworks Inc. — Investor Relations & Filings
Zymeworks Inc. is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. The company focuses on creating transformational therapies for patients with difficult-to-treat cancers and other serious diseases. Its product pipeline is driven by proprietary and clinically validated technology platforms for engineering next-generation antibody-drug conjugates (ADCs) and multispecific antibody therapeutics. Zymeworks operates as a royalty-driven organization with integrated in-house research and development capabilities, managing a portfolio of licensed healthcare assets while advancing its own novel therapeutic candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 8-K - Zymeworks Inc. (0001937653) (Filer) | 2026-04-01 | English | |
| 8-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | |
| 10-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | |
| 8-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | |
| 144 - Zymeworks Inc. (0001937653) (Subject) | 2026-02-14 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46279966 | 8-K | 2026-05-14 | English | ||
| 33133198 | 8-K - Zymeworks Inc. (0001937653) (Filer) | 2026-04-01 | English | ||
| 32900537 | 8-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | ||
| 32900538 | 10-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | ||
| 32900536 | 8-K - ZYMEWORKS INC. (0001937653) (Filer) | 2026-03-02 | English | ||
| 19635170 | 144 - Zymeworks Inc. (0001937653) (Subject) | 2026-02-14 | English | ||
| 32226759 | 3 Filing | 2026-02-02 | English | ||
| 13601615 | 4 | 2026-01-13 | English | ||
| 13601616 | 3 | 2026-01-13 | English | ||
| 13601617 | 4 | 2026-01-13 | English | ||
| 13601618 | 3 | 2026-01-13 | English | ||
| 13601619 | 4 | 2026-01-13 | English | ||
| 13601620 | 4 | 2026-01-13 | English | ||
| 13601621 | 4 | 2026-01-13 | English | ||
| 13601622 | 4 | 2026-01-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
A leading CDMO providing comprehensive, integrated pharmace…
|
6821 | HK | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
Atrium Therapeutics, Inc.
Pioneering precision RNA medicines for cardiac diseases, fo…
|
RNA | US | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
Zymeworks Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32180/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32180 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32180 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32180 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32180}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zymeworks Inc. (id: 32180)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.